E. V. Kryukova

E. V. Kryukova

Auto-generated profile, based on publicly available information

E. V. Kryukova

Russian Biotechnological University (ROSBIOTECH)

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2019 in Series of Geology and Technical Sciences
Verified
Journal Article
Closed access
DKD. V. Karpenko
D. V. Karpenko
MPMoscow State University of Food Production"
Moscow State University of Food Production"
RMRussia Moscow
Russia Moscow
MGM. V. Gernet
M. V. Gernet
EKE. V. Krjukova
E. V. Krjukova
EAElmira Assembayeva
Elmira Assembayeva

13 May 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VKV. M. Kodentsova
V. M. Kodentsova
DRD. V. Risnik
D. V. Risnik
EKE. V. Kryukova
E. V. Kryukova
SDS. G. Dariy
S. G. Dariy
L-carnitine plays a key role in cell bioenergetics, it belongs to vitamin-like substances, but unlike vitamins, it not only comes from food, but is also synthesized in the body. Endogenous synthesis decreases with age, under certain physiological conditions, taking medications. In this regard, specialized food products (SFP) and food supplements are being developed, containing L-carnitine as one of the functional ingredients. Comparison of doses of L-carnitine approved for use in biologically active food supplements and specialized food products with doses that provide a clinical effect.A review of existing literature on this issue in recent years was carried out using the RSCI, Pubmed databases and in the Google Scholar, ResearchGate systems. The amount of L-carnitine contained in a daily portion of SPP is established by domestic regulatory documents based on an adequate level of daily intake for adults, which is 300 mg and the upper permissible level of daily intake in the composition of SFP and food supplements is 900 mg/day. Reception of L-carnitine 1–2 g per day. within 5–12 weeks led to an increase in its concentration in the blood plasma, and also improved the indicators of the antioxidant status. Long-term intake of L-carnitine in doses of 2–3 g in patients with dyslipidemia, type 2 diabetes (DM2) and cardiovascular diseased (CVD) led to an improvement in the lipid profile of blood plasma, glycemic control, and had an anti-inflammatory effect. The condition for achieving a clinical effect in patients is long-term use and high doses. The intake of physiological doses of L-carnitine is appropriate for individuals from risk groups. Clinically effective doses of L-carnitine, when used for at least 12 weeks, correspond to or are 2 times higher than the upper permissible intake level in the composition of SPP and dietary supplements.

13 June 2023 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
VKV. M. Kodentsova
V. M. Kodentsova
DRD. V. Risnik
D. V. Risnik
EKE. V. Kryukova
E. V. Kryukova
SDS. G. Dariy
S. G. Dariy
Review was carried out using the RSCI, Google Scholar, Pubmed, and ReserchGate databases. When biologically active substances (BAS) are used as functional ingredients in the composition of specialized food products (SPP) of dietary therapeutic and dietary preventive nutrition, the problems of choosing their dose arise. There are epidemiological data on the level of consumption of BAS with food, an associative relationship between the level of consumption of biologically active substances and the risk of diseases, as well as the results of assessing clinical efficacy are described. The content of BAS is regulated by regulatory documents that establish an adequate and upper permissible level of consumption as part of the SPP.The purpose of the review is to assess the level of dietary intake of curcumin, carotenoids, β-glucans, and taurine, and to compare the doses allowed for use as part of the SPP with doses that provide a clinical effect. An analysis of literature data showed that the consumption of taurine with a normaldiet is 50–400 mg, curcumin – 10–1500 mg, β-carotene – 0.8–10 mg, lycopene – 5–10.5 mg, lutein – 1–3 mg, zeaxanthin – 0.1–0.6 mg, cereal β-glucans – 0.7–2.8 g, mushroom β-glucans – 0.9–1.8 g. With the exception of β-glucans, especially cereals, these values do not exceed the current upper allowable consumption level as part of the SPP. The results of clinical trials have shown that effective daily doses for lutein are 15 mg, taurine are 1.5–3 g, curcumin are 300–1600 mg, cereal β-glucans are 3–8 g, mushroom and yeast β-glucans are about 1 g. These data indicate the need to increase the amount of BAS as part of the SPP of dietary therapeutic nutrition to clinically justified values. At the same time, the given data indicate the expediency of differentiating the SPP, depending on the doses of BAS, into 2 categories: SPP for preventive and SPP for therapeutic action. SPP for dietary preventive nutrition is necessary to compensate the insufficient intake of essential micronutrients and achieve an adequate level of consumption of BAS, which will reduce the risk of alimentary-dependent diseases. In order to provide a clinical effect in pathological conditions, dietary therapeutic SPP should contain higher doses of biologically active substances that exceed the adequate intake level, but do not reach the upper safe intake level.

30 December 2019 in Health, Food & Biotechnology
Verified
Journal Article
Open access
PDF file
ИМИгорь Дмитриевич Мурашов
Игорь Дмитриевич Мурашов
ЕКЕлизавета Вячеславовна Крюкова
Елизавета Вячеславовна Крюкова
ЕГЕлена Давидовна Горячева
Елена Давидовна Горячева
АДАнна Эдуардовна Джабакова
Анна Эдуардовна Джабакова
ГПГригорий Викторович Парамонов
Григорий Викторович Парамонов
Одним из важнейших показателей качества и безопасности пищевой продукции является отсутствие посторонних включений. Посторонние включения представляют собой объекты, не характерные для данного пищевого продукта и видимые невооруженным глазом. К ним относятся различные упаковочные материалы (пластик, дерево, керамика и стекло), а также инородные материалы, которые могут попасть в пищевой продукт из-за нарушений технологических процессов или из-за неправильной эксплуатации оборудования (осколки кости в мясе, листья и стебли во фруктах, насекомые и др.). Анализ литературных источников свидетельствует о том, что перспективными средствами по обнаружению посторонних включений в пищевых продуктах являются такие виды контроля, которые, не изменяя качества, параметров и характеристик этих продуктов, позволяют по косвенным, второстепенным признакам обнаруживать посторонние включения. Целью настоящей работы являлась разработка метода определения основных параметров для обнаружения посторонних металлических и неметаллических включений в пищевых продуктах (в мясном фарше, в частности) на основе применения электромагнитных методов, селекции сигналов и автоматического удаления частиц из продукта в условиях непрерывного производственного процесса. Для изучения возможности применения электроконтактного метода для обнаружения посторонних частиц был выполнен расчет датчика- обнаружителя. Расчёт величины сигнала от посторонней частицы производился методом вторичного поля, который был реализован в устройстве (приборе) для обнаружения. На основании экспериментальных данных была построена круговая фазовая диаграмма вторичных полей локальных тел, которая показывает, что металлы и неметаллы имеют фазы сигналов, отличные как от контролируемых пищевых продуктов, так и между собой. Из этого следует, что возможно применение метода фазовой избирательности для селекции сигналов от металлических и неметаллических частиц, находящихся в пищевых продуктах. Разработанный обнаружитель состоит из датчиков и анализатора посторонних включений. Датчик состоит из 22 чувствительных элементов. Каждый из датчиков включен в мостовую измерительную схему. Проведенные исследования позволили разработать автоматическое устройство для удаления обнаруженных частиц без остановки технологического процесса при производстве колбасного фарша, экспериментальный образец которого был опробован в производственных условиях мясокомбината.

30 September 2026 in Izvestiya of Kabardino-Balkarian State Agrarian University named after V.M. Kokov
Verified
Journal Article
Closed access
EKElizaveta V. Kryukova
Elizaveta V. Kryukova
TTTatyana V. Tulyakova
Tatyana V. Tulyakova
NFNatalia V. Fomenko
Natalia V. Fomenko
SPStepan Yu. Paveliev
Stepan Yu. Paveliev
In the 21st century, food allergies have become a significant and challenging issue in healthcare, the food industry, and the catering industry. Although food allergies may affect a relatively small percentage of the population, allergic reactions can be severe and potentially fatal. Therefore, relevant regulations specify that food safety hazards include allergens. Furthermore, ingredients that can cause allergic reactions are listed in food products, regardless of their quantity. Currently, the negative impact of allergens on consumer health is primarily minimized through warning labeling of packaged food products. A specific feature of catering establishments is the inability to label each prepared dish before serving. Furthermore, the risk of cross-contamination with allergens during the preparation of cooked dishes in catering establishments increases due to the fact that dozens of different dishes are prepared simultaneously in a single room within a short time. Minimizing the risk of negative impact on consumer health from the presence of allergens in food prepared in catering establishments will be achieved by updating mandatory preliminary measures programs, which are implemented by HACCP-based safety management systems, using the VIAL® methodology, and by using a risk-based approach to allergen management.